Showing results (1-10 of 147) with videos related to

Sort By:
Pageof 15
Journal of the American Academy of Dermatology|April 25, 2009
Strategies for early melanoma detection: Approaches to the patient with neviAgnessa Gadeliya Goodson, Douglas Grossman
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|July 28, 2011
A decade of melanomas: identification of factors associated with delayed detection in an academic group practiceAgnessa Gadeliya Goodson, Scott R Florell, Kenneth M Boucher, et al.
Journal of the American Academy of Dermatology|December 19, 2009
Low rates of clinical recurrence after biopsy of benign to moderately dysplastic melanocytic neviAgnessa Gadeliya Goodson, Scott R Florell, Kenneth M Boucher, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|July 27, 2010
Comparative analysis of total body and dermatoscopic photographic monitoring of nevi in similar patient populations at risk for cutaneous melanomaAgnessa Gadeliya Goodson, Scott R Florell, Mark Hyde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2009
Use of oral N-acetylcysteine for protection of melanocytic nevi against UV-induced oxidative stress: towards a novel paradigm for melanoma chemopreventionAgnessa Gadeliya Goodson, Murray A Cotter, Pamela Cassidy, et al.
The Annals of Pharmacotherapy|October 18, 2012
Argatroban dose reductions for suspected heparin-induced thrombocytopenia complicated by child-pugh class C liver diseasePeter M Yarbrough, Amir Varedi, Amanda Walker, et al.
Pharmaceuticals (Basel, Switzerland)|January 8, 2020
ASA Suppresses PGE2 in Plasma and Melanocytic Nevi of Human Subjects at Increased Risk for MelanomaAmir Varedi, Hafeez Rahman, Dileep Kumar, et al.
Journal of the American Academy of Dermatology|June 19, 2012
The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical managementKeith Duffy, Douglas Grossman
Anticancer Research|January 31, 2012
Role of the apoptotic and mitotic regulator survivin in melanomaJodi A McKenzie, Douglas Grossman
Pageof 15